{"schema_version":"secwatch.filing_event.v1","accession":"0000885978-22-000055","form_type":"8-K","ticker":"USPH","cik":"0000885978","company_name":"U S PHYSICAL THERAPY INC /NV","filed_at":"2022-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.867769+00:00","generated_at":"2026-06-22T16:22:41.989854+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"USPH Q3 revenue $139.6M (+10.9%), GAAP EPS $0.72; cost pressures weigh on margins","bullets":["Net income $9.6M; GAAP diluted EPS $0.72 vs $0.66 a year ago; non-GAAP Operating Results $0.58 per share vs $0.78.","Adjusted EBITDA $17.0M, down from $19.6M; total operating costs rose to 80.8% of revenue from 76.3%.","IIP revenue all-time high of $20.2M, up 92.1%; physical therapy same-store visits declined 1.5%.","Board declared $0.41 quarterly dividend payable Dec 16, record Nov 21.","Guidance for full-year Operating Results $34.4-35.8M and Adjusted EBITDA $73.5-75.4M, likely low end."],"urls":{"canonical":"https://secwatch.observer/filing/0000885978-22-000055","json":"https://secwatch.observer/filing/0000885978-22-000055.json","markdown":"https://secwatch.observer/filing/0000885978-22-000055.md","text":"https://secwatch.observer/filing/0000885978-22-000055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885978/000088597822000055/0000885978-22-000055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885978/000088597822000055/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T16:22:41.989854+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"59fd713aa5db750a2cdefd589e6c04d1cd70d25a","claim":"U S PHYSICAL THERAPY INC /NV reported the third quarter and nine months ended September 30, 2022 results: revenue $139.6 million, net income $9.6 million, EPS $0.72. Guidance reaffirmed.","evidence_excerpt":"Third Quarter included a change in the fair value of a continent earn-out payment which had the effect of increasing net income by $1.5 million, net of tax. • Total revenue of $139.6 million for the 2022 Third Quarter was 10.9% higher than total revenue of $125.9 million for the 2021 Third Quarter. • Net patient revenue from physical therapy operations was $116.7","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/885978/000088597822000055/0000885978-22-000055-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter and nine months ended September 30, 2022"},{"label":"Revenue","value":"$139.6 million"},{"label":"Net income","value":"$9.6 million"},{"label":"EPS","value":"$0.72"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}